U.S. markets closed
  • S&P 500

    4,207.27
    -2.97 (-0.07%)
     
  • Dow 30

    33,336.67
    +27.16 (+0.08%)
     
  • Nasdaq

    12,779.91
    -74.89 (-0.58%)
     
  • Russell 2000

    1,975.26
    +6.01 (+0.31%)
     
  • Crude Oil

    94.00
    +2.07 (+2.25%)
     
  • Gold

    1,805.70
    -8.00 (-0.44%)
     
  • Silver

    20.26
    -0.48 (-2.32%)
     
  • EUR/USD

    1.0325
    +0.0023 (+0.23%)
     
  • 10-Yr Bond

    2.8880
    +0.1020 (+3.66%)
     
  • GBP/USD

    1.2197
    -0.0021 (-0.17%)
     
  • USD/JPY

    133.0300
    +0.1570 (+0.12%)
     
  • BTC-USD

    24,203.66
    +338.47 (+1.42%)
     
  • CMC Crypto 200

    573.13
    -1.61 (-0.28%)
     
  • FTSE 100

    7,465.91
    -41.20 (-0.55%)
     
  • Nikkei 225

    27,819.33
    -180.63 (-0.65%)
     

New Data Suggest GSK and Sanofi’s Covid Vaccine Could Pose a Challenge to Pfizer and Moderna

·2 min read
New Data Suggest GSK and Sanofi’s Covid Vaccine Could Pose a Challenge to Pfizer and Moderna
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

Sanofi and GSK's joint Covid-19 vaccine has finally produced data that could challenge the dominance of the Pfizer and Moderna vaccines.